Nuclear Medicine Software Market, By Type, By Modality, By Therapeutic Area, By Deployment Model, By Integration Complexity, By Pricing Model, By End User, By Geography

Description

Nuclear Medicine Software Market is estimated to be valued at USD 980.5 Mn in 2025 and is expected to reach USD 1,803.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 980.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2020 To 2024
Forecast Period 2025 to 2032 CAGR:	9.10%	2032 Value Projection:	USD 1,803.9 Mn

The global nuclear medicine software market represents a critical technological backbone supporting the rapidly evolving field of nuclear medicine and molecular imaging. This specialized software encompasses comprehensive solutions designed to facilitate the acquisition, processing, analysis, and management of nuclear medical imaging data, including SPECT, PET, and hybrid imaging modalities.

Nuclear medicine software plays an indispensable role in enhancing diagnostic accuracy, streamlining workflow efficiency, and supporting clinical decision-making across healthcare institutions worldwide. The market encompasses various software categories including image reconstruction software, quantitative analysis tools, reporting systems, and integrated hospital information management platforms.

As healthcare systems increasingly prioritize precision medicine and personalized treatment approaches, nuclear medicine software has emerged as a fundamental component enabling advanced molecular imaging techniques and radiopharmaceutical applications. The integration of artificial intelligence, machine learning algorithms, and cloud-based platforms has revolutionized traditional nuclear medicine practices, offering enhanced image quality, automated analysis capabilities, and improved patient throughput.

Market Dynamics

The global nuclear medicine software market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the increasing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, serving as a primary catalyst for market expansion as healthcare providers seek advanced diagnostic solutions to improve patient outcomes and treatment planning. The growing adoption of hybrid imaging technologies, including PET/CT and SPECT/CT systems, necessitates sophisticated software platforms capable of handling complex multi-modal data integration and analysis, thereby driving demand for comprehensive nuclear medicine software solutions.

Technological advancements in artificial intelligence and machine learning are significantly enhancing software capabilities, enabling automated image analysis, improved diagnostic accuracy, and reduced interpretation time, which attracts healthcare institutions seeking operational efficiency and clinical excellence. However, the market faces notable restraints including substantial implementation costs associated with advanced nuclear medicine software systems, which can burden healthcare facilities with limited budgets, particularly in emerging markets where cost-sensitivity remains a critical consideration. Additionally, the complexity of software integration with existing hospital information systems and regulatory compliance requirements create implementation challenges that may delay adoption timelines and increase operational overhead.

The shortage of skilled nuclear medicine professionals capable of effectively utilizing advanced software platforms also constrains market growth, as inadequate training and expertise can limit software utilization and return on investment. Despite these challenges, significant opportunities emerge through the expanding applications of nuclear medicine in precision medicine and theranostics, where software platforms can support personalized treatment approaches and radiopharmaceutical therapy monitoring. The increasing focus on value-based healthcare delivery models creates opportunities for software vendors to develop solutions that demonstrate measurable improvements in diagnostic efficiency, patient throughput, and clinical outcomes, thereby justifying investment costs and driving market penetration across diverse healthcare settings.

Key Features of the Study

This report provides in-depth analysis of the global nuclear medicine software market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nuclear medicine software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Bracco Imaging S.p.A. (via Advanced Accelerator Applications), Hermes Medical Solutions AB, Segami Corporation, MIM Software Inc., Mirada Medical Ltd., INVIA Medical Imaging Solutions, Mediso Medical Imaging Systems, Nuclear Diagnostics AB, Sofie Biosciences Inc., PMOD Technologies LLC, and Xeleris
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nuclear medicine software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine software market

Market Segmentation

Type Insights (Revenue, USD Mn, 2020 - 2032)
- Patient Data Management Software
- Imaging and Visualization Software
- Analysis and Quantification Software
- Clinical Decision Support Software
- Dosimetry Software
- Workflow and Scheduling Software
- Treatment Planning Software
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
Modality Insights (Revenue, USD Mn, 2020 - 2032)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Others (Planar Scintigraphy, hybrid systems)
Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Gastroenterology
- Others (Orthopedics, Infectious disease imaging, etc.)
Deployment Model Insights (Revenue, USD Mn, 2020 - 2032)
- On-Premise
- Cloud-Based
Integration Complexity Insights (Revenue, USD Mn, 2020 - 2032)
- Standalone Software
- Integrated Software Solutions
Pricing Model Insights (Revenue, USD Mn, 2020 - 2032)
- Subscription-based Pricing
- Perpetual License Pricing
- Usage-based Pricing (pay-per-use)
- Freemium or Trial-based Pricing
- Customized or Enterprise Pricing
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Hermes Medical Solutions AB
- Segami Corporation
- MIM Software Inc.
- Mirada Medical Ltd.
- INVIA Medical Imaging Solutions
- Mediso Medical Imaging Systems
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- PMOD Technologies LLC
- Xeleris

Product Code: CMI8470

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nuclear Medicine Software Market, By Type
- Global Nuclear Medicine Software Market, By Modality
- Global Nuclear Medicine Software Market, By Therapeutic Area
- Global Nuclear Medicine Software Market, By Deployment Model
- Global Nuclear Medicine Software Market, By Integration Complexity
- Global Nuclear Medicine Software Market, By Pricing Model
- Global Nuclear Medicine Software Market, By End User
- Global Nuclear Medicine Software Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Nuclear Medicine Software Market, By Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Patient Data Management Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Imaging and Visualization Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Analysis and Quantification Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Clinical Decision Support Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Dosimetry Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Workflow and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Treatment Planning Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Nuclear Medicine Software Market, By Modality, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Planar Scintigraphy, hybrid systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Nuclear Medicine Software Market, By Therapeutic Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Orthopedics, Infectious disease imaging, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Nuclear Medicine Software Market, By Deployment Model, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Nuclear Medicine Software Market, By Integration Complexity, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Standalone Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Integrated Software Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Nuclear Medicine Software Market, By Pricing Model, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Subscription-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Perpetual License Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Usage-based Pricing (pay-per-use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Freemium or Trial-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Customized or Enterprise Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Nuclear Medicine Software Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Nuclear Medicine Software Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hermes Medical Solutions AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Segami Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MIM Software Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mirada Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
INVIA Medical Imaging Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nuclear Diagnostics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sofie Biosciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PMOD Technologies LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xeleris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us